Consultant lobbyist
Shelley Case
- Meetings this Parliament
- 7
- Since Nov 2021
- 7
- Active registrations
- 1
Shelley Case's lobbying: the clients they represent and every meeting they've reported since November 2021.
← LobbyingConsultant lobbyist
Research to help find, treat and cure celiac disease to improve quality of life of those afflicted.
Seniors health, access to safe food in long term care and assisted living facilities
Research to help find, treat and cure celiac disease to improve quality of life of those afflicted.
Request amendments to the Income Tax Act to help remove the administrative barriers preventing Canadians affected by celiac disease from claiming the excess (incremental) cost of gluten-free products as a medical expense under section 118.2(2)(r) of the Act.
Public awareness of celiac disease in Canada to help improve diagnosis rates and improve quality of life.
Request amendments to the Income Tax Act to help remove the administrative barriers preventing Canadians affected by celiac disease from claiming the excess (incremental) cost of gluten-free products as a medical expense under section 118.2(2)(r) of the Act.
Public awareness of celiac disease in Canada to help improve diagnosis rates and improve quality of life.
Request amendments to the Income Tax Act to help remove the administrative barriers preventing Canadians affected by celiac disease from claiming the excess (incremental) cost of gluten-free products as a medical expense under section 118.2(2)(r) of the Act.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.